The Global Fibrin Sealants Market (2019-2023): Led by Baxter, CSL, Ethicon and Takeda Pharmaceutical - ResearchAndMarkets.com

December 4, 2018

DUBLIN--(BUSINESS WIRE)--Dec 4, 2018--The “Global Fibrin Sealants Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The Global Fibrin Sealants Market is forecast to grow at a CAGR of 8.09% during the period 2019-2023.

One trend affecting this market is the strong clinical trial pipeline. The number of products under clinical trial pipeline waiting for clearance from respective regulatory authorities in some countries is high. This will result in the launch of novel fibrin sealants during the forecast period.

According to the report, one driver influencing this market is the driven by the increasing number of surgical procedures. Fibrin sealants industry growth is expected to accelerate massively over the next five years driven by the increase in chronic conditions that have resulted in the rise of surgical procedures across the globe.

Further, the report states that one challenge affecting this market is the high cost of fibrin sealants. Fibrin sealants are found to be very effective to control bleeding, however their high cost is hindering the growth of the global fibrin sealant market.

Market Trends

Strong Clinical Trial Pipeline Adoption of Minimally Invasive & Robotic Surgeries Competitive Business Strategy

Key Vendors

Baxter CSL Ethicon Takeda Pharmaceutical

Topics Covered

1. Executive Summary

2. Scope of the Report

3. Market Landscape

4. Market Sizing

5. Five Forces Analysis

6. Market Segmentation by Product

7. Customer Landscape

8. Geographic Landscape

9. Decision Framework

10. Drivers and Challenges

11. Market Trends

12. Vendor Landscape

13. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/plvb7q/the_global_fibrin?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181204005516/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Hematological Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/04/2018 06:34 AM/DISC: 12/04/2018 06:34 AM


Update hourly